U-Blot® Research Grade NarsoplimabCat. No. WA3208$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade NarsoplimabCat. No. WA3208
U-Blot® Research Grade NarnatumabCat. No. WA3207
U-Blot® Research Grade NarlumosbartCat. No. WA3206
U-Blot® Research Grade NaratuximabCat. No. WA3205
U-Blot® Research Grade NaptumomabCat. No. WA3204
U-Blot® Research Grade NamilumabCat. No. WA3203
U-Blot® Research Grade Naglazyme/GalsulfaseCat. No. WA3202
U-Blot® Research Grade NadunolimabCat. No. WA3201
U-Blot® Research Grade NadecnemabCat. No. WA3200
U-Blot® Research Grade NacolomabCat. No. WA3199
U-Blot® Research Grade Myozyme/Alglucosidase AlfaCat. No. WA3198
U-Blot® Research Grade MuzastotugCat. No. WA3197